G. Hudson just published an article about the outcome of the suit between PharmAthene (NYSEMKT:PIP) and SIGA Technologies (NASDAQ:SIGA). The context is that in 2011, Vice Chancellor Parsons ruled that SIGA had both violated the doctrine of promissory estoppel and breached its contractual obligation to negotiate in good faith. He imposed a remedy consisting of an income stream that was to be paid only when there were profits, and he based the form of his remedy upon his finding that SIGA had committed both acts.
In May 2013, the Supreme Court agreed that SIGA had breached its contractual obligation to negotiate in good faith, but found that the doctrine of promissory estoppel did not apply because...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|